Within the Argon Plasma High Frequency Electrosurgical Unit segmentation, the market is principally divided by device architecture into three type categories: monopolar Argon plasma units, bipolar Argon plasma units, and hybrid systems that combine argon plasma with conventional radio‑frequency (RF) technology. Monopolar units dominate the segment, accounting for roughly 55 % of total unit shipments, because they deliver a broad, non‑contact plasma plume that is well‑suited for superficial coagulation of mucosal surfaces. Bipolar configurations, representing about 30 % of the market, incorporate a closed‑circuit electrode pair that confines the plasma field, thereby reducing collateral thermal spread and appealing to surgeons performing precise vascular or neurosurgical work. Hybrid systems, currently 15 % of the market, leverage the versatility of RF cutting alongside argon plasma coagulation, enabling a single platform to address both cutting and hemostasis in complex procedures. The relative contribution of each type to overall market size is driven by procedural volume, hospital procurement policies, and the cost‑benefit calculus of multi‑functionality versus single‑purpose equipment.